Alzheimer’s is far more than just memory loss – neuropsychiatric signs and symptoms can consist of nervousness, aggression and persona changes. These indicators aren’t just heartbreaking, they are marketing the burnout of caregivers. Cure is a lot more required than ever.
“People living with Alzheimer’s should have dignity in this stage of their everyday living,” stated Zach McMahon, CEO and co-founder of LUCID. “They are entitled to a procedure that is equally successful and can enrich high-quality of lifestyle for them and their caregivers.”
Before this year, LUCID’s initially randomized controlled clinical demo demonstrated scientific evidence in the reduction of acute stress within grown ups with moderate panic. With the support of JT, LUCID will translate their details-driven clinical insights into the development of a electronic therapeutic to reduce agitation and stress and anxiety in dementia care, to begin with with Alzheimer’s.
“Music interventions can ease these psychiatric symptoms and spark joy,” McMahon explained. “We’re dedicated to providing new care paradigms in an proof-dependent way.”
Now, with funding from JT, LUCID will conduct study and growth of the digital therapeutic that will be identified as LUC-101. Sheridan College’s Centre for Elder Investigate is also involved in the enhancement of LUC-101 through a Normal Sciences and Engineering Investigate Council of Canada (NSERC) initiative to assistance gerontological analysis and style and design.
LUCID will take a leadership place to deliver the electrical power of new music as drugs to individuals and caregivers globally. With LUC-101, LUCID strives to supply the added benefits of personalized tunes treatment for Alzheimer’s whilst reducing the general cost and barrier to entry by AI technologies and cloud-enabled programs.
About LUCID
LUCID develops therapeutic new music ordeals for mental health. By unlocking the electrical power of neuroscience and device finding out, LUCID’s AI curates new music encounters that are optimized for specific emotional results. They aim to present individualized, evidence-dependent, and available solutions in mental health treatment. LUCID is working in the direction of the clinical validation of songs as drugs.
JT, Japan Tobacco Inc., has a pharmaceutical business enterprise which focuses on investigation and development, producing and income of prescription prescription drugs. For a lot more information, you should check out https://www.jt.com/about/division/pharma/index.html.
Key phrase: JAPAN NORTH The us CANADA ASIA PACIFIC
Industry Key word: Analysis OTHER Well being Normal Overall health Entertainment PHARMACEUTICAL Mental Overall health Engineering Medical TRIALS SCIENCE Audio Option Medicine OTHER Technological know-how Health and fitness
Neighborhood Companions Executive Director, Brian Collins, to retire
DOVER — Wayne Goss, Neighborhood Associates Board President, has declared that Brian Collins has determined to retire immediately after serving 27 a long time as the agency’s Executive Director. Local community Companions is Strafford County’s Space Agency for Developmental Companies, Relatives Guidance Program, Early Supports and Providers Method, ServiceLink Middle, and Community Psychological Wellbeing Middle. They provide Strafford County individuals who expertise psychological distress, psychological health problems, co-happening material use diseases, developmental disabilities, chronic health and fitness wants, obtained brain disorder, as well as all those who require data and referral to access prolonged-term supports and services.
Collins’ tenure at the helm of Community Companions commenced in May possibly of 1995. Prior to his arrival he served as the Govt Director at The Moreover Enterprise in Nashua, from 1989 to 1995. The Furthermore Business is a nonprofit firm that serves more than 400 grownups with disabilities in Southern New Hampshire and the Higher Merrimack Valley in Massachusetts.
Goss expressed gratitude for Collins’ leadership at Community Associates and advocacy for people today with disabilities. “Brian has manufactured an huge effect in our community and state by working tirelessly to be certain all of our citizens are taken care of reasonably and have significant opportunities to take part in their communities, regardless of their developmental or behavioral problems. On behalf of our Board of Directors, we thank him for his management and commitment to our mission.”
The mission of Group Companions is to hook up our consumers and their families to prospects and possibilities for complete participation in their communities.
In his interaction to the employees of Group Partners, Collins said the Mission has been a driving power given that his arrival. “I have witnessed time and time once more the impression our perform has on individuals and people. This do the job is never ever about any 1 of us, it is about all of us and the men and women who depend on our guidance to get through their working day. Each individual day I am humbled by the determination of our team who tirelessly function to keep our buyers healthy and alive even though developing meaningful possibilities for them and their households to be part of our community.”
Collins went on to thank the Community Associates Board of Directors, declaring the “Board of Administrators have my deepest appreciation. I know they will be concentrated on furthering Community Partners’ capacity to make improvements to possibilities for the people today who require us.”
The system of selecting a new Govt Director will commence in February and is expected to acquire a number of months. Through the system Collins will stay with Neighborhood Associates to assure a easy changeover for the personnel, Board of Administrators and his successor.
ClearChoiceMD Urgent Care provides new healthcare solution to Seacoast
SEABROOK — ClearChoiceMD Urgent Care announced the opening of a new walk-in clinic in Seabrook that will present higher-good quality, hassle-free, and economical urgent care and occupational health solutions to the group. The new facility, located in Seabrook Commons at 636 Lafayette Street (Route 1), attributes numerous affected person rooms and is outfitted to address all urgent non-everyday living-threatening professional medical needs. The new ClearChoiceMD clinic will do the job in medical affiliation with Exeter Clinic and Main Medical professionals offering individuals access to major and specialty treatment providers, as very well as a coordinated Speedy Track plan for people who require an expedited referral to Main Orthopedics.
“When we open a new urgent treatment center, like the new Seabrook clinic, our aim is to increase value by integrating with present service provider networks to improve the overall high-quality of treatment for patients. Urgent treatment centers play an critical part in the health care continuum, and we feel it is essential to operate in conjunction with set up hospitals and main treatment physicians to complement professional medical expert services and make treatment more available to patients,” suggests ClearChoiceMD Urgent Treatment founder and CEO Marcus Hampers, MD.
ClearChoiceMD gives on-demand care for non-lifestyle-threatening diseases and accidents, these types of as sprains and strains, minor burns, coughs, sore throats, and flu-like symptoms. Also, it offers COVID-19 screening, physicals, vaccinations, and occupational health and fitness expert services. It also has on-website laboratory and x-ray services, as nicely as prescription drugs clients can get home.
ClearChoiceMD Urgent Care is based mostly in New London, N.H., and now operates 15 stroll-in facilities across the area. The latest urgent care middle, located in Seabrook Commons at 636 Lafayette Road (Route 1), Seabrook, was slated to open up Monday, Feb. 21.
Getting Tests to Heart – The Value of Cardiac Screening for Women of all ages
DOVER – Wentworth-Douglass Clinic Heart for Heart Health and fitness will be presenting a cost-free digital local community lecture titled Taking Checks to Coronary heart: The Significance of Cardiac Testing for Women on Thursday, Feb. 24 from 6 to 7 p.m. The function will be held by way of the Zoom system.
Attendees will study about the worth of cardiovascular screening, indications of heart disorder, and other ways girls can guarantee very good heart health. This local community training event will be hosted by Dr. Whitney Coppolino who leads Wentworth-Douglass’ Women’s Heart Well being Plan, in collaboration with the Massachusetts Standard Medical center Corrigan Women’s Heart Health Program.
Wentworth-Douglass Hospital’s Heart Wellbeing Center features detailed cardiac care. Board-accredited cardiologists and very-experienced nurses, medical doctor assistants, professionals and other scientific staff members get the job done together to supply large-quality diagnosis, main treatment plans and preventive care for heart individuals dealing with substantial blood tension, valve condition, coronary heart failure, and other types of heart condition.
Wentworth-Douglass funds Teen Mental Wellness First Support Schooling
DOVER – Dover Mental Wellness Alliance will be able to fund two several years of its Teenager Mental Wellbeing To start with Assist Coaching many thanks to a $7,500 neighborhood reward grant from the Wentworth-Douglass Healthcare facility Neighborhood Profit Endeavor Force.
“This initiative is just just one large phase to support modify our culture, and assist our youth, when it comes to psychological health. Wentworth-Douglass is, when yet again, enjoying a substantial function in making our neighborhood a superior area to stay, increase, and be healthy,” stated Suzanne Weete, a person of the founders of the Dover Mental Well being Alliance.
Teen Psychological Overall health Initially Assist teaches teenagers in grades 10 to 12, or ages 15 to 18, how to detect, realize, and react to indicators of mental wellness and compound use worries among the their friends and friends. Teenagers will study the techniques they need to have supportive conversations with their good friends and how to get assistance from a dependable and reliable adult.
“We believe this essential software will have a meaningful affect on the health and fitness and wellbeing of younger folks in our group,” explained Jeff Hughes, President, and CEO of Wentworth-Douglass. “We are happy to be equipped to fund this training for two far more a long time to enable our teenagers navigate the critical concern of psychological wellbeing and empower them to treatment for other folks.”
Wentworth-Douglass conducts a Local community Wellness Needs Assessment each three several years as component of its motivation to the community’s properly-getting. The effects of the 2019 Youth Risk Behavioral Survey showed that psychological health was an area that desires important consideration.
“The healthcare facility is keen to guidance this essential initiative to enable teenagers detect warning signs, stimulate them to get enable, conclude stigma, and support suicide avoidance,” said Michelle Hanson, Director of Strategic Preparing and Group Advantage. “Helping Seacoast adolescents navigate these challenges can support direct to a much healthier local community.”
The cash donated are accepted by the hospital’s Community Gain Funding Disbursement Committee and are not raised by way of any public or private donations.
Qualified teen psychological well being very first help trainers from the Dover Mental Health and fitness Alliance and Dover Large College launched tMHFA to the 10th graders having wellbeing course this past fall. The other half of the 10th grade class will also be experienced as teenager mental health initially aiders this spring in health class. The 4-day course teaches youth how to figure out threat aspects and warning symptoms of a mental health crisis in their peers, to master how to method their good friends appropriately, and to then get help from a experienced.
“If you saw a human being tumble and break their arm, you’d do what you can, with the techniques that you have, to assist that man or woman. That may perhaps just be by calling 911, which is thoroughly proper. This is the identical with teen mental health and fitness first help. It does not teach you to diagnose a trouble, but it does teach you how to identify that something is not ideal with a close friend and to be in a position to reply properly in the second by finding the enable of a educated specialist. It truly is initially help, for psychological health,” Weete stated.
If you or anyone you know is enduring a mental wellness crisis, get in touch with the Countrywide Suicide Prevention Lifeline (Lifeline) by dialing 800-273-Communicate (8255) or the Disaster Text Line: 741741. These traces are staffed 24/7 by skilled mental health pros.
Review more supports the enlargement of medical trials of MYCO-001 for the treatment method of PTSD between the Veteran inhabitants
DENVER, Jan. 24, 2022 (Globe NEWSWIRE) — Mydecine Improvements Team (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology and electronic technology firm aiming to rework the treatment of mental health and fitness and dependancy disorders, currently declared a partnership with Beat Strain (Overcome Stress) and the King’s Higher education London to use psilocybin as part of a psychoactive-assisted psychotherapy remedy for submit-traumatic anxiety dysfunction (PTSD) in veterans. Beat Anxiety will be just one of numerous sites for Mydecine’s upcoming scientific trials.
Overcome Tension is the main charity aiding veterans’ mental wellbeing in the United Kingdom, supplying remedy and support to previous servicemen and ladies for about a century. They deliver a variety of on the internet, community, outpatient and household expert psychological overall health companies to veterans with intricate psychological well being difficulties similar to their armed forces company.
Professor Dominic Murphy, Head of Investigation at Fight Stress and President of the British isles Psychological Trauma Society, has been named a Principal Investigator for the examine which will benefit from Mydecine’s lead psilocybin drug candidate, MYCO-001, as an adjunct to psychotherapy to treat extreme PTSD in veterans that has normally been resistant to standard sorts of therapy. Details gathered from the analyze will even further advance Mydecine’s drug development pipeline and their potential to deliver a a lot desired novel therapy to market.
“I am really fired up to be top this analyze at Battle Stress,” said Professor Murphy. “We know that the gold typical treatment plans for PTSD, supplied by Battle Pressure and other organizations, function for most veterans. Even so, for a minority, their signs and symptoms do not boost. This collaboration offers great potential for research centered on new, revolutionary therapeutics that give important chances to deliver hope to all those veterans continue to residing with the trauma of their navy encounters.”
Mydecine Main Health-related Officer, Dr. Rakesh Jetly, explained, “The crew is thrilled to be conducting scientific studies inside the veteran population where the assistance is required most. During my 31 several years as a clinical officer and psychiatrist in the Canadian Armed Forces, I have viewed initial hand the impact PTSD has on our vets and their people. Sadly, quite a few troopers and veterans do not answer to the evidence-based mostly therapies easily accessible to them and the research is on for new secure and powerful therapies. Our troops struggle and sacrifice alongside one another, so it only would make feeling that we enable them heal collectively.”
Mydecine CEO, Josh Bartch, claimed, “This partnership serves as one more important chance to extend our clinical trials and provide on our mission to create protected and helpful different drugs folks can trust. There is a huge unmet need to have when it arrives to treating PTSD and other mental wellbeing disorders, specifically within the veteran population, and this partnership demonstrates the powerful progress we continue on to make in bringing psychoactive-assisted psychotherapies to the forefront of the marketplace and bring hope for all those having difficulties with these ailments.”
Mydecine Improvements Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology and electronic technological innovation company acquiring ground breaking initially-and-second-generation novel therapeutics for the cure of psychological well being and dependancy by means of environment-course technologies and drug progress infrastructure. Mydecine Innovations Team was launched in 2020 on the guiding principle that there is a considerable unmet require and absence of Improvements in the mental well being and therapy environments. Mydecine Innovations Team is devoted to effectively establishing impressive therapeutics to take care of PTSD, depression, panic, addiction, and other psychological overall health diseases. Mydecine Innovations Group’s company model brings together clinical trials and information consequence, engineering, scientific and regulatory abilities with a focus on psychedelic treatment underpinned by other novel molecules with differentiated therapeutic opportunity. By collaborating with some of the world’s foremost authorities connected by finest tactics, Mydecine Innovations Group aims to responsibly rapidly-monitor the development of new medicines across its platforms, trying to get to efficiently take care of and in the long run modify the way we take care of psychological wellbeing diseases. Mydecine Improvements Group’s eyesight is to bridge the latest gap concerning what the cognitive healthcare program at present gives with the requires of the patients. Mydecine Improvements Group is headquartered in Denver, Colorado, Usa, with worldwide workplaces in Leiden, Netherlands.
Investor & Media Get in touch with Morgan Kervitsky, Director of Advertising (720) 689-4638 [email protected]
On behalf of the Board of Administrators: Joshua Bartch, Main Govt Officer speak [email protected]
For even further information about Mydecine Innovations Team, Inc., please stop by the Company’s profile on SEDAR at www.sedar.com or stop by the Company’s web site at www.mydecine.com.
This news release consists of forward-searching facts in just the that means of Canadian securities legal guidelines relating to the Enterprise and its enterprise, which relate to foreseeable future functions or potential overall performance and reflect management’s present-day anticipations and assumptions. Generally but not normally, forward-on the lookout information and facts can be identified by the use of text such as “expect”, “intends”, “anticipated”, “believes” or versions (which include detrimental versions) of these words and phrases and phrases, or state that specified actions, gatherings or effects “may”, “could”, “would” or “will” be taken, arise or be attained. These kinds of forward-seeking statements replicate management’s recent beliefs and are primarily based on assumptions made by and data presently obtainable to the Enterprise. Visitors are cautioned that these forward-searching statements are neither promises nor ensures, and are subject matter to threats and uncertainties that may cause potential effects to differ materially from all those predicted like, without having limitation, threats with regards to the COVID-19 pandemic, the availability and continuity of funding, the means of the Company to adequately protect and enforce its intellectual house, the Company’s capability to bring its products to professional output, continued advancement of the worldwide adaptive pathway medication, purely natural health products and digital health industries, and the dangers presented by the extremely controlled and competitive industry concerning the improvement, generation, sale and use of the Firm’s merchandise. While the Firm has tried to establish vital elements that could induce actual effects to differ materially from individuals contained in ahead-seeking info, there may possibly be other variables that induce outcomes not to be as expected, approximated or supposed. There can be no assurance that this kind of data will confirm to be exact, as precise outcomes and long term activities could vary materially from people anticipated in such facts. These ahead-looking statements are manufactured as of the day hereof and the Enterprise does not suppose any obligation to update or revise them to mirror new occasions or circumstances preserve as demanded underneath applicable securities legislation.
Elevate ENT Partners (“Elevate” or the “Company”), a primary administration service corporation of ear, nose, and throat (“ENT”) procedures nationwide, today announced that it has acquired Orlando Ear, Nose & Throat, P.A. (“Orlando ENT”). Orlando ENT’s health practitioner associates will be a part of Elevate, which gives assistance and instruments to aid ENT methods accelerate advancement.
The acquisition expands Elevate’s footprint in Central Florida, a strategic area that will enable the group to access and handle a lot more individuals as it continues to increase in the Florida sector.
“Elevate ENT offers us the capital to assistance us increase with other like-minded ENT procedures across Florida and Texas. We imagine the scale of the group and their small business sophistication will support just take our follow to the subsequent amount. We are thrilled to be part of Elevate ENT, where by we will be in a position to truly aim our notice on client treatment,” explained Michael M. Bibliowicz, Senior Companion and Co-Founder of Orlando ENT.
Elevate ENT Associates invests in non-public ENT and allergy tactics throughout the United States and offers scalable infrastructure to help techniques to the up coming stage in phrases of money administration, internet marketing, contracting, human methods, and other critical business enterprise disciplines. The Company is actively pursuing new partnerships in the Florida and Texas marketplaces, and seeking to expand into new geographies.
“This acquisition carries on our national development enlargement and is the third significant a single in the past year. We are delighted to have Orlando ENT join the Elevate relatives. The doctors have a name for providing compassionate affected individual care that aligns with our significant requirements,” said James Polfreman, CEO of Elevate.
“Elevate is thrilled to lover with Orlando ENT and welcomes their effectively-highly regarded medical practitioners into our spouse and children,” stated Dr. Jonathan Cooper, Healthcare Director of Elevate. “As an corporation started and led by medical professionals, we value patient outcomes and the healthcare experience of our medical professionals earlier mentioned all else, and are fully commited to securing their lengthy-time period accomplishment.”
With over 80 places of work throughout three observe models, Elevate ENT Companions is on a mission to eradicate limitations to high quality individual treatment by offering private otorhinolaryngology tactics with steadiness, capital investment decision, and the assets they need to have to mature their methods and elevate their futures. As a medical professional-led organization, we set individual outcomes first, eliminate boundaries to excellent patient treatment, and aid ENT practitioners progress their professions.
NextSense, the foundation of mind health and fitness, came out of stealth with an announcement created from the AES (American Epilepsy Culture) Once-a-year Meeting in Chicago, where NextSense and its associates are presenting the benefits of their research on seizure detection to peers in academia and business for the first time.
NextSense unlocks brain health with true environment info insights and functional, scientific knowledge for each day living. Regular brain wellbeing checking technology like EEG equipment and polysomnograms are far too cumbersome for dwelling use, requiring people to stay overnight at hospitals or slumber review clinics for observation. The large charge of treatment and lack of consolation of these devices helps make prolonged-time period and continual checking just about difficult. Not only are these knowledge based mostly on a one timeframe, they notice what is nearly anything but an standard night’s sleep. And for anybody living with epilepsy, the unpredictability of seizures helps make immediate observation and significant-high quality information-accumulating exceedingly rare.
The NextSense system commences with longitudinal EEG information gathered at the position of practical experience with biosensing earbuds that can be worn comfortably at night time and as-essential throughout the day. The organization envisions combining that data with environmental and behavioral designs collected from intelligent products and well timed evaluation from its crew of neuroscientists to enable health professionals recognize triggers, diagnose sure circumstances and tailor treatment and medication tips in genuine-time.
At the AES Yearly Meeting, NextSense thorough for the initial time its vital connection with biopharma husband or wife UCB. The firm also revealed exploration and IP agreements with both of those Heraeus and UC San Diego, as perfectly as a multi-dimensional collaboration with scientists at Emory College.
“We imagine that technologies that help previously detection of seizures and make improvements to the coordination of care for people living with epilepsy enhance UCB’s strong heritage in epilepsy and portfolio of medications,” claimed Colin Lake, Vice President of Digital Business Transformation for Neurology at UCB. “Being capable to accessibility significant info that NextSense can give will permit us to seize insights and resolve complex disease thoughts that will support epilepsy sufferers on their care journey realize superior outcomes.”
Just about every pharma and biotech enterprise has partnered with NextSense to examine how neurologists can improved calibrate and manage treatment ideas for epilepsy, rest, and likely other CNS diseases, using the company’s system.
Emory University’s Brain Well being Heart, led by entire world-renowned medical doctor-scientist Allan Levey, is the website of multiple NextSense reports and its initially two clinical trials.
“We are thrilled for what this partnership indicates for equally NextSense and Emory Mind Health and fitness,” stated Allan Levey, Founding Director of Goizueta Institute at Emory Mind Health. “Our do the job together with Emory’s Division of Biomedical Informatics signifies a noteworthy action ahead towards continual ambulatory checking of brain physiology by using EEG. With their earbuds enabling obtain for checking information more than a lot extended intervals of time, the preliminary conclusions and foundational work are extremely promising and demonstrating how their endeavours and technological know-how has major prospective to revolutionize the technique to diagnosing and managing several neurological conditions in the upcoming.”
“We’ve assembled a desire group of collaborators,” stated Jonathan Berent, Founder and CEO of NextSense. “It is a personalized and skilled thrill to associate with these innovators at the quite best of their field. Our partners have labored with us shoulder-to-shoulder to methodically pursue what numerous folks mentioned was unachievable. We are beyond thrilled to commence to exhibit the planet what we have obtained, commencing with the scientific community at AES.”
NextSense is continuing to enroll participants in medical trials concentrated on epilepsy and slumber. At some point, the company hopes to leverage the extensive-time period knowledge gathered to enable build biomarkers for brain health and fitness.
“Whether somebody is living with epilepsy, struggling to keep alert, or in search of an elusive prognosis for a neurological problem, we’re giving hope,“ mentioned Jen Dwyer, Medical Director of NextSense. “We see our members from every single angle, and we comprehend their special discomfort factors. We’re operating to a environment the place all those who go through from these conditions really don’t have to decide on concerning comfort and accuracy. And we’re just having began.”
About NextSense, Inc.
NextSense is the basis of a nutritious mind.
We unlock mind well being with actual-planet data insights and sensible, scientific wisdom for daily living. Irrespective of whether you are battling to continue to be notify, residing with some thing like epilepsy, in search of an elusive analysis for a neurological problem, we can assistance.
We are a passionate team of neuroscientists and enterprise operators on a mission to catalyze brain health and fitness in both science and tradition.
Market Keyword: Study General Health PHARMACEUTICAL Psychological Overall health Professional medical Devices University Training Medical TRIALS SCIENCE BIOTECHNOLOGY Alternate Drugs Wellness OTHER SCIENCE
Resource: NextSense, Inc.
Copyright Organization Wire 2021.
PUB: 12/03/2021 10:00 AM/DISC: 12/03/2021 10:02 AM
SAN CARLOS, Calif.–(BUSINESS WIRE)–IncellDx’s Chronic COVID Treatment Center (CCTC) (www.covidlonghaulers.com) and ARISE™ MD Integrative Medicine & Surgery announced today a new partnership to evaluate CCR5 antagonists and statins as a potential therapeutic treatment approach for chronic COVID, also known as long COVID or post-acute sequelae of COVID-19 (PASC).
In a randomized, placebo controlled trial led by co-Investigator Adam Miller, MD, CEO, Medical Director, ARISE, a combination of maraviroc, a CCR5 antagonist, and a commonly administered statin, atorvastatin, will be evaluated for its efficacy in alleviating PASC symptoms.
In the trial, under an Enriched Enrollment Randomized Withdrawal (EERW) design, patients who experience symptomatic improvement with maraviroc and atorvastatin in an open label phase will enter a second phase and be randomized to continue active treatment or placebo.
The study aims to support clinical approaches developed by IncellDx’s Chronic COVID Treatment Center, which has enrolled more than 12,000 patients and published multiple articles on the application of precision medicine and biomarkers to determine the underlying pathways involved in PASC.
“At CCTC, we provide consultation to physicians across the country who are treating patients with chronic COVID,” said internist and physician Eric Osgood MD, physician, CCTC. “We are excited to partner with Dr. Miller to further evaluate the clinical observation that a biomarker-driven, precision medicine approach can result in improvement of long COVID symptoms as well as resolution of abnormal cytokine profiles that may be the underlying cause of this condition. In continuing to advance new research into diagnostic criteria and clinical approaches to treatment, we aim to provide lasting symptom alleviation in patients with PASC.”
“Based on outcomes we observe in long COVID patients being treated under the CCTC program protocol, we believe this condition can be objectively assessed and that addressing immune disruption from PASC may be central to its treatment,” said Dr. Miller. “Through this study, we aim to assess whether reducing the activity of CCR5 in the body with the use of CCR5 antagonists can play an important role in treatment of long COVID. We’ll also be evaluating the potential for the IncellDx Long Hauler Index, or LHI, to provide important diagnostic information about this condition that can inform treatment. We’re very excited about the potential of this study to validate clinical application of IncellDx’s LHI and a novel combination therapeutic approach leveraging already commonly used medicines.”
About IncellDx
IncellDx is a precision medicine company advancing novel diagnostics and prognostics to better understand and treat infectious disease and cancer. The company’s innovative technology platform enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. The company launched the Chronic COVID Treatment Center to apply precision medicine approaches to evaluate, characterize and more effectively address chronic COVID.
About the Long Hauler Index
The Long Hauler Index or LHI was developed and patented by IncellDx to provide an objective method of identifying patients suffering from long COVID or PASC. The LHI assesses cytokines and chemokines believed to cytokine storm conditions and chronic COVID patients (often referred to as COVID “long haulers”).
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
